Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Docherty

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Inorganic Biochemistry|February 24, 2020
Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donorsReece G Kenny, Ziga Ude, James R Docherty, et al.
Advances in Therapy|August 27, 2016
Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine TherapyJames R Docherty, Martin Steinhoff, Dianne Lorton, et al.
European Journal of Gastroenterology & Hepatology|October 19, 2018
Patterns of splenic arterial enhancement on computed tomography are related to changes in portal venous pressureP Aiden McCormick, Dermot E Malone, James R Docherty, et al.
British Journal of Pharmacology|March 10, 2018
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewersMichael J Curtis, Steve Alexander, Giuseppe Cirino, et al.
British Journal of Pharmacology|December 19, 2022
Guidance for the use and reporting of anaesthetic agents in BJP manuscripts involving work with animalsJerry Ingrande, Hemal H Patel, Dave Kendall, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Inorganic Biochemistry|February 24, 2020
Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donorsReece G Kenny, Ziga Ude, James R Docherty, et al.
Advances in Therapy|August 27, 2016
Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine TherapyJames R Docherty, Martin Steinhoff, Dianne Lorton, et al.
European Journal of Gastroenterology & Hepatology|October 19, 2018
Patterns of splenic arterial enhancement on computed tomography are related to changes in portal venous pressureP Aiden McCormick, Dermot E Malone, James R Docherty, et al.
British Journal of Pharmacology|March 10, 2018
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewersMichael J Curtis, Steve Alexander, Giuseppe Cirino, et al.
British Journal of Pharmacology|December 19, 2022
Guidance for the use and reporting of anaesthetic agents in BJP manuscripts involving work with animalsJerry Ingrande, Hemal H Patel, Dave Kendall, et al.
Pageof 5